Lanean...

Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Immunother Cancer
Egile Nagusiak: Koelzer, Viktor H., Buser, Tobias, Willi, Niels, Rothschild, Sacha I., Wicki, Andreas, Schiller, Peter, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://ncbi.nlm.nih.gov/pubmed/27532022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0151-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!